Stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 play an important role in the carcinogenesis and metastasis of tumors. CXCR4 can be a potential target for the in vivo imaging of tumors. T140 is a specific antagonist of chemokine receptor CXCR4. By optimizing the reaction parameters
a peptide ligand of CXCR4
[18F]FB-AcTZ14011 was prepared through 18F labeled prosthetic group [18F]SFB and coupled with the analog of the peptide T140. After HPLC purification
radiochemical purity of the labeled peptide was more than 96%
and [18F]FB-AcTZ14011 was produced in 3 h with a radiochemical yield of 3% (without decay-correction).